Journal: International Journal of Pharmaceutics: X

Article Title: Allicin-based biomimetic nanoparticles of the erythrocyte membrane for the delivery of lumefantrine to enhance its antimalarial effect

doi: 10.1016/j.ijpx.2026.100487

Figure Lengend Snippet: In vivo therapeutic effect of PECm-Allicin@LM. A Schematic of the treatment plan. B Peripheral blood smear subjected to Giemsa staining ( Pb ANKA-infected erythrocytes marked with a black arrow). C Survival curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). D Infection rate curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). E Weight curves for ICR mice in different groups ( n = 10). F Red blood cell count in peripheral blood samples from ICR mice in different groups ( n = 6). G Hemoglobin concentration in peripheral blood samples from ICR mice in different groups ( n = 6). H Appearance of livers from ICR mice in different groups. Data are presented as mean ± SEM, and * P < 0.05, ** P < 0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Article Snippet: A Giemsa staining kit was purchased from Nanjing Jiancheng Bioengineering Research Institute Co., Ltd. (China).

Techniques: In Vivo, Staining, Infection, Cell Characterization, Concentration Assay